Cell cultures of the retinal pigment epithelium to model the blood–retinal barrier for retinal drug and gene delivery

1992 ◽  
Vol 33 (4) ◽  
pp. 562-562
Author(s):  
Sigeki Takahasi ◽  
Izuru Asaoka ◽  
Hirosi Takamura ◽  
Takeo Satoh

1993 ◽  
Vol 106 (3) ◽  
pp. 859-867 ◽  
Author(s):  
L.J. Rizzolo ◽  
Z.Q. Li

The retinal pigment epithelium lies at the interface between the neural retina and the choriocapillaris where it forms a blood-retinal barrier. Barrier function requires a polarized distribution of plasma membrane proteins and ‘tight’ tight junctions. During chicken embryogenesis, these features develop gradually. Although terminal junctional complexes are established by embryonic day 4, the distribution of the Na+/K(+)-APTase is not polarized in all cells of the epithelium until embryonic day 11. Similarly, the tight junctions of early embryos are leaky, but become tight by hatching (embryonic day 21). We used primary cell culture to examine the molecular basis of this gradual induction of polarized function. Pigment epithelium harvested from embryonic day 7, and cultured on filters, formed monolayers coupled by junctional complexes. The distribution of the Na+/K(+)-ATPase was non-polarized and the tight junctions were leaky with a transepithelial electrical resistance of 20–30 omega cm2. To isolate diffusible factors that stimulate the transepithelial electrical resistance, neural retinas from embryonic day 7, 14 or 16 embryos were incubated at 37 degrees C in base medium for 6 hours. The conditioned medium was added to the apical chamber of freshly cultured pigment epithelium. The distribution of the Na+/K(+)-ATPase became basolateral, and the electrical resistance gradually increased two to three times over 6 days. The increase in electrical resistance corresponded to a decrease in the rate of [3H]inulin diffusion across the monolayer. The effectiveness of the conditioned medium increased steadily with increasing age of the neural retina. Rather than increased production of an active factor, apparently different active factors were produced at different ages.(ABSTRACT TRUNCATED AT 250 WORDS)


2021 ◽  
Author(s):  
Minh-Anh Nguyen Ngo Le ◽  
Yao-Tseng Wen ◽  
Dieu-Thuong Thi Trinh ◽  
Rong - Kung Tsai

Abstract Background: Puerarin, an isoflavonoid, is a neuroprotectant against many ischemic brain injuries. The research purpose was to investigate whether puerarin treatment can inhibit hypoxia-induced apoptosis and barrier breakdown on human retinal pigment epithelium (ARPE-19) cells.Methods: Treatment with 100 µM of puerarin showed no ARPE-19 cytotoxicity. Treatments with 50 µM or 100 µM of puerarin significantly preserved cell viability under hypoxic conditions for 12 h (p < 0.05). Moreover, treatments with 50 µM and 100 µM of puerarin significantly reduced the proportion of Annexin V- and PI-positive ARPE cells under hypoxic conditions (p < 0.05). The TER analysis and junctional protein staining demonstrated that treatments with 50 µM or 100 µM of puerarin prevented the hypoxia-induced barrier disruption in APRE-19 cultures. In contrast to the untreated group, treatment with puerarin significantly increased the level of Bcl-2 and decreased the levels of p-Bad, Bax, and cleaved caspase 3 in RPE cell under hypoxic conditions (p < 0.05). Treatment with puerarin maintained Akt1 activation in the ARPE-19 cells under hypoxic conditions (p < 0.05), and inhibition of PR-induced Akt1 activation abolished the protective effect of puerarin in ARPE-19 cells under hypoxic conditions.Conclusion: Our results demonstrated that treatment with puerarin protected RPE cell against hypoxia-induced blood-retinal barrier breakdown and Akt-dependent apoptosis. These findings suggest that puerarin could be developed as an alternative treatment for ischemic and hypoxic retinal injuries.


Sign in / Sign up

Export Citation Format

Share Document